Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee
Clinical trial NCT04120402 · COMPLETED
Trial details
- NCT number
- NCT04120402
- Sponsor
- Eupraxia Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2023-05-17
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.